Jpmorgan Chase & CO Biotechnology

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ATHA Athira Pharma, Inc.	$13.2M	$0 0.0% of portfolio	143	Q4 2024 Reduced 97.84%
BYSI Beyond Spring Inc.	$62.3M	$0 0.0% of portfolio	600	Q4 2024 New
BCAB Bio Atla, Inc.	$12.7M	$0 0.0% of portfolio	1,129	Q3 2024 Reduced 86.46%
BTAI Bio Xcel Therapeutics, Inc.	$65.3M	$0 0.0% of portfolio	1,328	Q4 2024 Added 77.3%
BOLT Bolt Biotherapeutics, Inc.	$16.6M	$0 0.0% of portfolio	911	Q4 2024 Reduced 0.33%
CSBR Champions Oncology, Inc.	$130M	$0 0.0% of portfolio	11	Q4 2023 Added 809.09%
CGTX Cognition Therapeutics Inc	$10.2M	$0 0.0% of portfolio	75	Q4 2024 Reduced 3.85%
CNTB Connect Biopharma Holdings LTD	$44M	$0 0.0% of portfolio	121	Q4 2023 Reduced 99.49%
CNTX Context Therapeutics Inc.	$12.3M	$0 0.0% of portfolio	166	Q4 2024 Reduced 4.05%
AIKI A Ikido Pharma Inc.	$20.8M	$0 0.0% of portfolio	9	Q1 2024 Reduced 11.11%
DYAI Dyadic International Inc	$40.1M	$0 0.0% of portfolio	29	Q2 2023 Reduced 97.58%
EQ Equillium, Inc.	$26.5M	$0 0.0% of portfolio	41	Q4 2024 Reduced 4.65%
EPIX Essa Pharma Inc.	$69.6M	$0 0.0% of portfolio	21	Q4 2023 Reduced 99.93%
EYEN Eyenovia, Inc.	$47.2M	$0 0.0% of portfolio	723	Q1 2024 Added 1,679.25%
FGEN Fibrogen Inc	$30M	$0 0.0% of portfolio	567	Q4 2024 Reduced 99.97%
GLYC Glycomimetics Inc	$14.2M	$0 0.0% of portfolio	136	Q4 2024 Reduced 3.55%
IMMX Immix Biopharma, Inc.	$25M	$0 0.0% of portfolio	38	Q4 2024 New
ICCC Immucell Corp	$37.9M	$0 0.0% of portfolio	11	Q3 2024 Reduced 15.38%
INAB In8 Bio, Inc.	$5.64M	$0 0.0% of portfolio	112	Q4 2024 Added 31.76%
INDP Indaptus Therapeutics, Inc.	$5.95M	$0 0.0% of portfolio	19	Q3 2024 Added 26.67%
KRON Kronos Bio, Inc.	$49.4M	$0 0.0% of portfolio	448	Q4 2024 Reduced 0.88%
MAIA Maia Biotechnology, Inc.	$19.2M	$0 0.0% of portfolio	45	Q4 2024 Reduced 4.26%
NERV Minerva Neurosciences, Inc.	$9.24M	$0 0.0% of portfolio	17	Q4 2024 New
INKT Mi Nk Therapeutics, Inc.	$307M	$0 0.0% of portfolio	325	Q4 2024 Added 151.94%
NBTX Nanobiotix S.A.	$128M	$0 0.0% of portfolio	256	Q4 2024 New
NXTC Next Cure, Inc.	$17.2M	$0 0.0% of portfolio	805	Q4 2024 Reduced 0.25%
NTRB Nutri Band Inc.	$52.5M	$0 0.0% of portfolio	12	Q3 2024 Reduced 33.33%
NVCT Nuvectis Pharma, Inc.	$149M	$0 0.0% of portfolio	179	Q4 2024 Reduced 6.77%
OMGA Omega Therapeutics, Inc.	$479K	$0 0.0% of portfolio	503	Q3 2024 Reduced 0.2%
ONVO Organovo Holdings, Inc.	$27.4M	$0 0.0% of portfolio	40	Q3 2024 Reduced 45.21%
PASG Passage Bio, Inc.	$24.5M	$0 0.0% of portfolio	273	Q4 2023 Added 404.4%
PMCB Pharma Cyte Biotech, Inc.	$32.8M	$0 0.0% of portfolio	18	Q3 2024 Reduced 5.26%
CRTX Cortexyme, Inc.	$70.5M	$0 0.0% of portfolio	545	Q4 2024 Reduced 0.55%
RLYB Rallybio Corp	$21.5M	$0 0.0% of portfolio	948	Q4 2024 Added 7.48%
RANI Rani Therapeutics Holdings, Inc.	$38M	$0 0.0% of portfolio	71	Q1 2024 Added 17,767.61%
RNXT Renovo Rx, Inc.	$8.7M	$0 0.0% of portfolio	40	Q4 2024 New
RVPH Reviva Pharmaceuticals Holdings, Inc.	$21.3M	$0 0.0% of portfolio	235	Q4 2024 New
SNSE Sensei Biotherapeutics, Inc.	$15.1M	$0 0.0% of portfolio	705	Q4 2024 Reduced 0.28%
SPRB Spruce Biosciences, Inc.	$8.01M	$0 0.0% of portfolio	69	Q4 2024 Reduced 2.82%
UNCY Unicycive Therapeutics, Inc.	$10.2M	$0 0.0% of portfolio	199	Q4 2024 Reduced 3.86%
VIGL Vigil Neuroscience, Inc.	$53.4M	$0 0.0% of portfolio	382	Q4 2024 Reduced 7.73%
VINC Vincerx Pharma, Inc.	$13.8M	$0 0.0% of portfolio	23	Q4 2024 Reduced 60.34%
VIRX Viracta Therapeutics, Inc.	$751K	$0 0.0% of portfolio	721	Q4 2022 Reduced 67.87%
XLO Xilio Therapeutics, Inc.	$21.7M	$0 0.0% of portfolio	66	Q4 2024 Reduced 12.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.